A novel model to combine clinical and pathway-based transcriptomic information for the prognosis prediction of breast cancer.

This is expected given their highly significant p-values (1.92e-7 and 4.93e-8, respectively) in the univariate Cox-PH models ( Figure 1B and 1E ), as well as relatively large coefficients in the clinical model (0.27 and 0.36, respectively).

also in 132,142 other papers